Literature DB >> 22031810

Invited Commentary on: Can CD44+/CD24- Tumor Stem Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy?

Jeong Eon Lee1, Seok Jin Nam.   

Abstract

Entities:  

Year:  2011        PMID： 22031810      PMCID： PMC3200524          DOI： 10.4048/jbc.2011.14.3.251

Source DB:  PubMed          Journal:  J Breast Cancer        ISSN： 1738-6756            Impact factor:   3.588


× No keyword cloud information.
  9 in total

1.  Sometimes a great notion--an assessment of neoadjuvant systemic therapy for breast cancer.

Authors:  Nancy E Davidson; Monica Morrow
Journal:  J Natl Cancer Inst       Date:  2005-02-02       Impact factor: 13.506

2.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

3.  Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.

Authors:  Emmanuelle Charafe-Jauffret; Christophe Ginestier; Flora Iovino; Carole Tarpin; Mark Diebel; Benjamin Esterni; Gilles Houvenaeghel; Jean-Marc Extra; François Bertucci; Jocelyne Jacquemier; Luc Xerri; Gabriela Dontu; Giorgio Stassi; Yi Xiao; Sanford H Barsky; Daniel Birnbaum; Patrice Viens; Max S Wicha
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

4.  Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.

Authors:  Sara Ricardo; André Filipe Vieira; Renê Gerhard; Dina Leitão; Regina Pinto; Jorge F Cameselle-Teijeiro; Fernanda Milanezi; Fernando Schmitt; Joana Paredes
Journal:  J Clin Pathol       Date:  2011-06-16       Impact factor: 3.411

5.  Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

Authors:  Xiaoxian Li; Michael T Lewis; Jian Huang; Carolina Gutierrez; C Kent Osborne; Meng-Fen Wu; Susan G Hilsenbeck; Anne Pavlick; Xiaomei Zhang; Gary C Chamness; Helen Wong; Jeffrey Rosen; Jenny C Chang
Journal:  J Natl Cancer Inst       Date:  2008-04-29       Impact factor: 13.506

6.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.

Authors:  Elgene Lim; François Vaillant; Di Wu; Natasha C Forrest; Bhupinder Pal; Adam H Hart; Marie-Liesse Asselin-Labat; David E Gyorki; Teresa Ward; Audrey Partanen; Frank Feleppa; Lily I Huschtscha; Heather J Thorne; Stephen B Fox; Max Yan; Juliet D French; Melissa A Brown; Gordon K Smyth; Jane E Visvader; Geoffrey J Lindeman
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

7.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

Authors:  Christophe Ginestier; Min Hee Hur; Emmanuelle Charafe-Jauffret; Florence Monville; Julie Dutcher; Marty Brown; Jocelyne Jacquemier; Patrice Viens; Celina G Kleer; Suling Liu; Anne Schott; Dan Hayes; Daniel Birnbaum; Max S Wicha; Gabriela Dontu
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

Review 8.  Stem cells in normal breast development and breast cancer.

Authors:  Gabriela Dontu; Muhammad Al-Hajj; Wissam M Abdallah; Michael F Clarke; Max S Wicha
Journal:  Cell Prolif       Date:  2003-10       Impact factor: 6.831

9.  Can CD44+/CD24- Tumor Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy?

Authors:  Hong Wu; Ruhui Li; Xiaodong Hang; Ming Yan; Feng Niu; Lidi Liu; Wei Liu; Song Zhao; Shaokun Zhang
Journal:  J Breast Cancer       Date:  2011-09-29       Impact factor: 3.588
  9 in total
  2 in total

Review 1.  Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity.

Authors:  Appalaraju Jaggupilli; Eyad Elkord
Journal:  Clin Dev Immunol       Date:  2012-05-30

2.  Human Medulloblastoma Cell Lines: Investigating on Cancer Stem Cell-Like Phenotype.

Authors:  Arianna Casciati; Mirella Tanori; Rémi Manczak; Sofiane Saada; Barbara Tanno; Paola Giardullo; Elena Porcù; Elena Rampazzo; Luca Persano; Giampietro Viola; Claire Dalmay; Fabrice Lalloué; Arnaud Pothier; Caterina Merla; Mariateresa Mancuso
Journal:  Cancers (Basel)       Date:  2020-01-17       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.